|
1
|
Outwater EK, Siegelman ES and Hunt J: L:
Ovarian teratomas: Tumor types and imaging characteristics.
Radiographics. 21:475–490. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jorge S, Jones NL, Chen L, Hou JY, Tergas
AI, Burke WM, Ananth CV, Neugut AI, Herhshman DL and Wright JD:
Characteristics, treatment and outcomes of women with immature
ovarian teratoma, 1998-2012. Gynecol Oncol. 142:261–266. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hung YC, Chang WC, Chen LM, Chang YY, Wu
LY, Chung WM, Lin TY, Chen LC and Ma WL: Non-genomic
estrogen/estrogen receptor α promotes cellular malignancy of
immature ovarian teratoma in vitro. J Cell Physiol. 229:752–761.
2014. View Article : Google Scholar
|
|
4
|
Chan JK, Gardner AB, Chan JE, Guan A,
Alshak M and Kapp DS: The influence of age and other prognostic
factors associated with survival of ovarian immature teratoma-A
study of 1307 patients. Gynecol Oncol. 142:446–451. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eidem TM, Kugel JF and Goodrich JA:
Noncoding RNAs: Regulators of the mammalian transcription
machinery. J Mol Biol. 428:2652–2659. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet. 15(Spec No 1): R17–R29. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X,
Wang M, Huang C, Wang L, Zeng F and Jiang G: LncRNA SPRY4-IT1
sponges miR-101-3p to promote proliferation and metastasis of
bladder cancer cells through up-regulating EZH2. Cancer Lett.
388:281–291. 2017. View Article : Google Scholar
|
|
10
|
Huang J, Chen YX and Zhang B: IGF2-AS
affects the prognosis and metastasis of gastric adenocarcinoma via
acting as a ceRNA of miR-503 to regulate SHOX2. Gastric Cancer.
23:23–38. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
12
|
Franken NA, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar
|
|
13
|
Chang RK, Li X, Mu N, Hrydziuszko O,
Garcia-Majano B, Larsson C and Lui WO: MicroRNA expression profiles
in non-epithelial ovarian tumors. Int J Oncol. 52:55–66. 2018.
|
|
14
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B,
Du Y, Gao G, Tian Y, He L and Fan Z: LncBRM initiates YAP1
signalling activation to drive self-renewal of liver cancer stem
cells. Nat Commun. 7:136082016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li N, Zeng J, Sun F, Tong X, Meng G, Wu C,
Ding X, Liu L, Han M, Lu C and Dai F: p27 inhibits CDK6/CCND1
complex formation resulting in cell cycle arrest and inhibition of
cell proliferation. Cell Cycle. 17:2335–2348. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Q and Lozano G: Molecular pathways:
Targeting Mdm2 and Mdm4 in cancer therapy. Clin Cancer Res.
19:34–41. 2013. View Article : Google Scholar :
|
|
19
|
Siddik ZH: Chapter 12-Apoptosis in cancer:
Mechanisms, deregulation, and therapeutic targeting. Cancer Drug
Design and Discovery. Neidle S: 2nd edition. Academic Press; San
Diego, CA: pp. 357–390. 2014, View Article : Google Scholar
|
|
20
|
Liu C, Kelnar K, Liu B, Chen X,
Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, et
al: The microRNA miR-34a inhibits prostate cancer stem cells and
metastasis by directly repressing CD44. Nat Med. 17:211–215. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Y, Ponnusamy M, Zhang L, Zhang Y, Liu
C, Yu W, Wang K and Li P: The role of miR-214 in cardiovascular
diseases. Eur J Pharmacol. 816:138–145. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng C, Guo K, Chen B, Wen Y and Xu Y:
MiR-214-5p inhibits human prostate cancer proliferation and
migration through regulating CRMP5. Cancer Biomark. 26:193–202.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pang J, Li Z, Wang G, Li N, Gao Y and Wang
S: MiR-214-5p targets KLF5 and suppresses proliferation of human
hepatocellular carcinoma cells. J Cell Biochem. Sep 11–2018.Epub
ahead of print.
|
|
24
|
Cao TH, Ling X, Chen C, Tang W, Hu DM and
Yin GJ: Role of miR-214-5p in the migration and invasion of
pancreatic cancer cells. Eur Rev Med Pharmacol Sci. 22:7214–7221.
2018.PubMed/NCBI
|
|
25
|
Wu S, Gu Z, Wu Y, Wu W, Mao B and Zhao S:
LINC00324 accelerates the proliferation and migration of
osteosarcoma through regulating WDR66. J Cell Physiol. 235:339–348.
2020. View Article : Google Scholar
|
|
26
|
Pan ZH, Guo XQ, Shan J and Luo SX:
LINC00324 exerts tumor-promoting functions in lung adenocarcinoma
via targeting miR-615-5p/AKT1 axis. Eur Rev Med Pharmacol Sci.
22:8333–8342. 2018.PubMed/NCBI
|
|
27
|
Zou Z, Ma T, He X, Zhou J, Ma H, Xie M,
Liu Y, Lu D, Di S and Zhang Z: Long intergenic non-coding RNA 00324
promotes gastric cancer cell proliferation via binding with HuR and
stabilizing FAM83B expression. Cell Death Dis. 9:7172018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
VanArsdale T, Boshoff C, Arndt KT and
Abraham RT: Molecular pathways: Targeting the cyclin D-CDK4/6 axis
for cancer treatment. Clin Cancer Res. 21:2905–2910. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jirawatnotai S, Hu Y, Livingston DM and
Sicinski P: Proteomic identification of a direct role for cyclin d1
in DNA damage repair. Cancer Res. 72:4289–4293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shadfan M, Lopez-Pajares V and Yuan ZM:
MDM2 and MDMX: Alone and together in regulation of p53. Transl
Cancer Res. 1:88–89. 2012.PubMed/NCBI
|
